MiMedx Group, Inc.
MiMedx Group, Inc. scores highest on Earnings (84) and lowest on Price (27). Its PosiPenta is 55.55 out of 100, around the middle of similar companies.
On the Penta Grid this week, MiMedx Group, Inc. is Grid #203 of 837 in the Healthcare sector in United States, and Grid #1,176 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| MiMedx Group, Inc. | 55.55 | 27 | 84 | 56 | 66 | 46 |
| ProKidney Corp. | 35.77 | 0 | 40 | 27 | 57 | 54 |
| Phathom Pharmaceuticals, Inc. | 49.53 | 0 | 66 | 30 | 95 | 58 |
| Electra Therapeutics, Inc. | 35.43 | 0 | 26 | 41 | 68 | 42 |
| Puma Biotechnology, Inc. | 64.40 | 50 | 47 | 93 | 77 | 55 |
| GMR Solutions Inc. | 42.85 | 43 | 61 | 53 | 4 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 110.75 |
| P/B ratio | 2.99 |
EEarnings
| Trailing EPS | ₹3.79 |
| Forward EPS | ₹12.94 |
NNitro
| Price | 419.59 |
| 52-week high | 754.88 |
| 52-week low | 286.99 |
| Fall from 52-week high | 44.4% |
TTorque
| Return on equity (ROE) | 2.88% |
| Debt-to-equity | 0.08 |
AAnchor
| Beta (price swings) | 1.17 |
| Market cap | ₹6,123 Cr |
| Insider holding | 2.14% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is MiMedx Group, Inc.'s PosiPenta score?
MiMedx Group, Inc.'s PosiPenta is 55.55 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does MiMedx Group, Inc. stand on the Penta Grid?
On the Penta Grid this week, MiMedx Group, Inc. is Grid #203 of 837 in the Healthcare sector in United States, and Grid #1,176 of 4,000 in United States.
Which PosiPenta pillar is strongest for MiMedx Group, Inc.?
Earnings (growth), with a score of 84 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for MiMedx Group, Inc.?
Price (valuation), with a score of 27 out of 100: weaker than most similar companies.
Has MiMedx Group, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.46 points, from 53.09 to 55.55.
PositoAI is for research and education only and is not investment advice.